Adenoid cystic carcinoma of the breast

Monika Olszewska; Stanisław Głuszek

doi:10.5114/ms.2017.72484

eISSN: 2300-6722
ISSN: 1899-1874

Medical Studies/Studia Medyczne

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2017
vol. 33

Send email

Copy url:

abstract:

Review paper

Adenoid cystic carcinoma of the breast

Monika Olszewska

¹

,

Stanisław Głuszek

^{1, 2, 3}

Clinic of Oncological Surgery, Holycross Cancer Center, Kielce, Poland
Clinic of General, Oncological and Endocrine Surgery, Regional Hospital, Kielce, Poland
Department of Sugery and Surgical Nursing with a Laboratory for Scientific Research, Institute of Medical Sciences, Faculty of Medicine and Health Science, Jan Kochanowski University, Kielce, Poland

Medical Studies/Studia Medyczne 2017; 33 (4): 304–307

DOI: https://doi.org/10.5114/ms.2017.72484

Online publish date: 2017/12/31

View full text Get citation

PlumX metrics:

Adenoid cystic carcinoma is an invasive cancer accounting for less than 0.1% of all breast cancers. It most frequently occurs as a single, clearly defined, tender tumour. Mammographic and ultrasound images are non-characteristic and may be misinterpreted as benign change. This cancer shows no expression of ER, PGR, and HER-2 receptors; however, as opposed to triple-negative breast cancers, NST has a mild course and sporadically gives rise to metastases to locoregional lymph nodes and distant metastases. There is no consensus concerning the optimum treatment. The surgeries usually performed are lumpectomy with an open sentinel lymph node biopsy and mastectomy. However, considering the low probability of the presence of metastases in the lymph nodes, doubts arise pertaining to the justification for lymph node resection. Adjuvant radiotherapy is recommended after breast-conserving surgeries, especially with positive margins. The role of chemotherapy has not been well recognised, and hormone therapy is not recommended.

keywords:

Adenoid cystic carcinoma of the breast

Monika Olszewska 1 , Stanisław Głuszek 1, 2, 3

adenoid cystic carcinoma of the breast, breast cancer, diagnostics, treatment

Monika Olszewska

¹

,

Stanisław Głuszek

^{1, 2, 3}